Among the recent examples: iPSC model of cardio-facio-cutaneous syndrome (CFCS) resulting from germline mutations in BRAF, enabled to show that differentiation of mutated iPSCs towards CMs leads to fibroblast-like cells that influence CM hypertrophy through TGFβ [46]. The gene discussed is BRAF; the disease is cardiofaciocutaneous syndrome 1.